The Queensland Government is now in caretaker mode until after the state election. Minimal updates will be made to this site until after the election results are declared.
3D printed cardiovascular components
QUT bluebox has developed technology to 3D print diseased heart valve and vascular tissue replacements to patient specifications and fully mimic the properties of normal vascular tissue.
Unique selling point/competitive advantage
The 3D printed components have anisotropic and elastic properties identical to normal vascular tissue. The specific microstructure and layer arrangement of the printed structures allow the printed components to fully mimic the tissue they are replacing. This avoids the replacement, degeneration and thrombogenic issues of competing technologies.
Investment or collaboration opportunities
QUT bluebox is looking for an industry partner to assist with preclinical testing of the technology, regulatory planning and licensing to launch the technology into clinical application.
Intellectual property rights
QUT has filed 2 provisional patents that cover novel aspects of the melt electrospinning process and the structures produced.
General Manager, Commercial Operations
- Last reviewed: 17 Jul 2019
- Last updated: 29 May 2018